Patents by Inventor Robert Salatinjants

Robert Salatinjants has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulation Solution Adapted to Prolong Plasma Times of Drugs in Mammals Including Humans
    Publication number: 20160287711
    Abstract: Prolongation compositions for prolonging the presence of drugs in blood.
    Type: Application
    Filed: June 15, 2016
    Publication date: October 6, 2016
    Inventors: Aida Salatinjants, Robert Salatinjants
  • Formulation Solution Adapted to Prolong Plasma Times of Drugs in Mammals Including Humans
    Publication number: 20150087656
    Abstract: Prolongation compositions for prolonging the presence of drugs in blood.
    Type: Application
    Filed: November 26, 2014
    Publication date: March 26, 2015
    Inventors: Aida Salatinjants, Robert Salatinjants
  • Formulation Solution Adapted to Prolong Plasma Times of Drugs in Mammals Including Humans
    Publication number: 20140378557
    Abstract: Prolongation compositions for prolonging the presence of drugs in blood.
    Type: Application
    Filed: August 20, 2014
    Publication date: December 25, 2014
    Inventors: Aida Salatinjants, Robert Salatinjants
  • Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans
    Publication number: 20130158132
    Abstract: The composition adapted to prolong the residence time of drugs in the circulating plasma of mammals including humans comprises the following: Pectin 0.94 g Potassium bitartrate 0.48 g Tannic acid ?0.8 g L-Tyrosine 0.21 g Riboflavin 2 ml 10% solution of 15% Ethyl Alcohol Hexanoic Acid (Caproic acid) 0.06 ml Ethyl Alcohol 15% Ethyl Alcohol to make 100 ml The composition adapted to prolong the residence time of drugs in the circulating plasma of mammals including humans comprises the following: Pectin 0.94 g Potassium bitartrate 0.48 g Tannic acid ?0.8 g Glutamic acid 0.21 g Riboflavin 2 ml 10% solution of 15% Ethyl Alcohol Hexanoic Acid (Caproic acid) 0.
    Type: Application
    Filed: December 19, 2011
    Publication date: June 20, 2013
    Inventors: Aida Salatinjants, Robert Salatinjants